Member Info for pkwendall

"Do you believe him?"

I'm invested on ODX, so YES

https://twitter.com/HondJoe/status/1412666666555674624?s=20

https://t.co/d3IohI2Uwo?amp=1

What is changing?
From July 2021 all NHS staff will move to a new system where they will be able to order their own LFD testing kits from www.gov.uk/order-coronavirus-rapid-lateral-flow-tests. The testing kits will enable colleagues to carry out regular testing for COVID-19 at home.

The test kits provided via the new system may be different type, it is important that staff familiarise themselves with the tests and the instruction leaflet each time they receive a new box.

This move will not only make best use of LFDs currently available to Test and Trace but will also provide a greater level of assurance by organisation that devices are routinely being ordered and used.

Please note, the statutory requirement to report all test results has not changed and staff must report all results in line with their organisation’s policy.

Before moving to the new system trusts are to use up their existing stock of Innova 25s and should continue to provide staff with boxes until they have run out.

https://twitter.com/pk_wendall/status/1412746978979635207?s=20

“Working night and day to build up our domestic LFT capacity, and continue to do so....” (Boris Johnson, today in Parliament)

* Nice and concise Twitter thread from Shredz

https://twitter.com/Shredz90/status/1410912349901426691?s=20

https://twitter.com/Shredz90/status/1410912349901426691?s=20

Hopefully we'll hear something very soon on these approvals.

https://www.omegadiagnostics.com/Portals/0/ODX%20Regulatory%20progress%20for%20VISITECT%20COVID-19%20Antigen%20test%20%2808_06_21%29.pdf

With all the nonsense going on with the UK government, it's easy to forget that there's potentially a huge market in the USA & Europe for Omega diagnostics/Mologic's VISITECT® brand LTF, which is in the final stage for FDA approval.
Hold for gold, as they say.

Regulatory approvals
Omega announces that it has begun the process of engagement with its European Notified Body seeking CE marking of
the VISITECT® COVID-19 Antigen test, a rapid point-of-care diagnostic test for the detection of active COVID-19
infections as a self-test. The Company is agreeing the protocols required for utilisation studies and will update
shareholders as this process progresses. The test is already CE marked for professional-use and the Company is
targeting approval by the end of July to allow the test to be sold in Europe for home-use as well. As the global market
for Antigen testing develops the Company believes self-test approval will be a key product differentiator, as has already
been seen in the UK.
The Company also announces that its technology partner, Mologic Ltd (“Mologic”) has successfully completed the
necessary performance studies required for regulatory approval in the US and is now in the final stages of preparing a
submission to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) for its rapid
point-of-care COVID-19 antigen test, for use under both the Omega’s VISITECT® brand and Global Access Diagnostics
brand.

“be greedy when others are fearful”
With all the focus on the UK government’s shenanigans, people are forgetting that there’s a huge potential market for Omega & Mologic in Europe and the USA, with news due very soon. Serious money to be made. Strong buy and Hold. IMO

Hopefully the government will walk away from Innova's contract. The FDA and Innova have provided an easy ‘out’ for UK Govt here. They can just say they were “duped” into this massive order/contract under false/fake data.

"Strong close. Good luck & hold strong ODX LTHs ??"
Oops.. Those question marks should be a flexed bicep!

Strong close. Good luck & hold strong ODX LTHs ??

https://twitter.com/BigBiteNow/status/1397502064935247873?s=19

https://twitter.com/BigBiteNow/status/1397511970790727682?s=19

Fighting COVID-19 will require a holistic approach that includes scaling up testing, according to Charlotte Diez-Bento, who works in the external relations and communications division at the Global Fund to Fight AIDS, Tuberculosis, and Malaria.

https://www.globalcitizen.org/en/content/why-covid-19-testing-matters-as-vaccines-roll-out/

https://twitter.com/pk_wendall/status/1395299046932238336?s=19

https://twitter.com/Abingdon_Health/status/1395289325735235588?s=19

https://twitter.com/tom_the_bomb__/status/1395272393451573252?s=19

"18% margin of 374m???????"

No. The 18% margin is only for phase 1 (set-up phase)

"For creating the capacity in Phase 1 of the Contract ODX will make 18% Margin."

Yes, and we've seen a 50% margin being talked about , once ODX are in full swing. Fingers crossed.

https://twitter.com/tom_the_bomb__/status/1394578469443538946?s=20

https://twitter.com/OmegaDiagnostic/status/1387041625164029968?s=19

#ODX
1 million AbC-19 tests are currently being used by the DHSC within the UK Biobank study, so therefore the £6.7m will get paid, and it's only a matter of time before other orders start rolling in.
AbC-19 and the RTC are not the only strings to ODX's bow.